Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Properties and Activity of Peptide Derivatives of ACE2 Cellular Receptor and Their Interaction with SARS-CoV-2 S Protein Receptor-Binding Domain.

Autor: Sidorova MV; Chazov National Medical Research Center for Cardiology, Ministry of Health of the Russian Federation, Moscow, Russia., Bibilashvili RS; Chazov National Medical Research Center for Cardiology, Ministry of Health of the Russian Federation, Moscow, Russia., Avdeev DV; Chazov National Medical Research Center for Cardiology, Ministry of Health of the Russian Federation, Moscow, Russia., Kozhokar US; Chazov National Medical Research Center for Cardiology, Ministry of Health of the Russian Federation, Moscow, Russia., Palkeeva ME; Chazov National Medical Research Center for Cardiology, Ministry of Health of the Russian Federation, Moscow, Russia., Ovchinnikov MV; Chazov National Medical Research Center for Cardiology, Ministry of Health of the Russian Federation, Moscow, Russia., Molokoedov AS; Chazov National Medical Research Center for Cardiology, Ministry of Health of the Russian Federation, Moscow, Russia., Shirokov DA; Federal Research and Clinical Center of Physical Chemical Medicine, Federal Medical Biological Agency, Moscow, Russia.; Skryabin Moscow State Academy of Veterinary Medicine and Biotechnology, Moscow, Russia., Semyonova AV; Federal Research and Clinical Center of Physical Chemical Medicine, Federal Medical Biological Agency, Moscow, Russia., Uvarova VI; Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences (Institute of Poliomyelitis), Moscow, Russia., Kulyaev PO; Sirius University of Science and Technology, Sochi, Russia., Khvatov EV; Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences (Institute of Poliomyelitis), Moscow, Russia., Ignatova AA; Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia., Feofanov AV; Lomonosov Moscow State University, Moscow, Russia., Osolodkin DI; Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences (Institute of Poliomyelitis), Moscow, Russia.; Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia., Porozov YB; Sirius University of Science and Technology, Sochi, Russia.; Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia., Kozlovskaya LI; Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences (Institute of Poliomyelitis), Moscow, Russia. kozlovskaya_li@chumakovs.su.; Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia. kozlovskaya_li@chumakovs.su., Ishmukhametov AA; Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences (Institute of Poliomyelitis), Moscow, Russia.; Sechenov First Moscow State Medical University (Sechenov University), Moscow, Russia., Parfyonova YV; Chazov National Medical Research Center for Cardiology, Ministry of Health of the Russian Federation, Moscow, Russia., Egorov AM; Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences (Institute of Poliomyelitis), Moscow, Russia.; Lomonosov Moscow State University, Moscow, Russia.

Publikováno v: Doklady. Biochemistry and biophysics [Dokl Biochem Biophys] 2022 Dec; Vol. 507 (1), pp. 237-241. Date of Electronic Publication: 2022 Dec 29.

[Peptide inhibitors of the interaction of the SARS-CoV-2 receptor-binding domain with the ACE2 cell receptor].

Autor: Bibilashvili RS; National Medical Research Center for Cardiology, Moscow, Russia., Sidorova MV; National Medical Research Center for Cardiology, Moscow, Russia., Dudkina US; National Medical Research Center for Cardiology, Moscow, Russia., Palkeeva ME; National Medical Research Center for Cardiology, Moscow, Russia., Molokoedov AS; National Medical Research Center for Cardiology, Moscow, Russia., Kozlovskaya LI; Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences, Moscow, Russia; Sechenov Moscow State Medical University, Moscow, Russia., Egorov AM; Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences, Moscow, Russia; Lomonosov Moscow State University, Moscow, Russia., Ishmukhametov AA; Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products of the Russian Academy of Sciences, Moscow, Russia; Sechenov Moscow State Medical University, Moscow, Russia., Parfyonova YV; National Medical Research Center for Cardiology, Moscow, Russia.

Publikováno v: Biomeditsinskaia khimiia [Biomed Khim] 2021 May; Vol. 67 (3), pp. 244-250.

[Protective action of a modified fragment of galanine in rats with doxorubicin-induced heart failure].

Autor: Studneva IM; National Medical Research Center for Cardiology, Moscow, Russia., Palkeeva ME; National Medical Research Center for Cardiology, Moscow, Russia., Veselova OM; National Medical Research Center for Cardiology, Moscow, Russia., Molokoedov AS; National Medical Research Center for Cardiology, Moscow, Russia., Lubimov RO; National Medical Research Center for Cardiology, Moscow, Russia., Ovchinnikov MV; National Medical Research Center for Cardiology, Moscow, Russia., Sidorova MV; National Medical Research Center for Cardiology, Moscow, Russia., Pisarenko OI; National Medical Research Center for Cardiology, Moscow, Russia.

Publikováno v: Biomeditsinskaia khimiia [Biomed Khim] 2019 Jan; Vol. 65 (1), pp. 51-56.